news
Takeda to acquire ARIAD Pharmaceuticals
The transaction has been approved unanimously by the boards of directors of both companies, and is expected to close by the end of February 2017.
List view / Grid view
Funding
Drug discovery research is funded primarily by government and by philanthropic groups. Later development is funded mainly by pharmaceutical companies.
news
Researchers find a potential target for anti-Alzheimer treatments
The USP9 gene has an indirect influence on the so-called tau protein, which is believed to play a significant role in the onset of Alzheimer’s disease.
news
Macrophage raises £9 million & acquires immune-oncology technology
Macrophage Pharma, a newly formed immune-oncology company, has successfully raised £9 million in a Series A equity financing round.
news
Kymab receives $9m R+D grant from Bill & Melinda Gates Foundation
The monoclonal antibody biopharmaceutical group Kymab announced today that it has received a $9m grant from the Bill & Melinda Gates Foundation to accelerate the development of novel vaccines and therapeutics for infectious diseases, including HIV.
news
Kymab secures $100 million Series C funding
1 December 2016 | By Niamh Louise Marriott, Digital Editor
The funds will enable Kymab to advance its proprietary pipeline of first-in-class therapeutic human monoclonal antibodies, with clinical development in 2017...
news
German Research Foundation (DFG) gives €87 million to fund 20 new research groups
29 November 2016 | By Niamh Louise Marriott, Digital Editor
The Research Training Groups will receive funding of around €87 million for an initial period of four and a half years...
news
Promising antibiotic programme gets European boost
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers at the University of Oxford have been working with two major EU-funded projects to deliver a novel antibiotic programme for clinical development...
news
New scientific fellowship program launched for psoriatic arthritis research
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Five European research institutions have come together in recognition of the need to advance knowledge on the pathophysiology of psoriatic arthritis...
news
Personalised breast cancer programme launches in Cambridge
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The project will analyse the genome and all expressed genes of tumour cells from 250 breast cancer patients to improve diagnosis and tailor treatment...
news
Cell Medica and Baylor to develop off-the-shelf CAR-NKT cells for cancer treatment
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Cell Medica has expanded its partnership with Baylor College of Medicine to develop an off-the-shelf allogeneic cell therapy, using T (NKT) cells...
news
Marker for aggressive prostate cancer doubles-up as a drug target
10 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer...
news
HIV test performed on USB stick
10 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The technology could enable patients with HIV to be managed more effectively in remote locations and can produce a result in under 30 minutes...
news
€6 million for innovation in science, engineering and technology education
8 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The EU and the Swiss government gave €6.3 million for the Next-Lab project, which aims to bring changes in the way that science, engineering and technology are taught in Europe...
news
€3.2 million grant for medical fibre optics research
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The fibre optics research at KTH covers everything from bio-implants via medical sensors to solar cells and the researchers aim to have developed several...
news
Newly discovered protein may hold key to better drugs for neglected diseases
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Bicyclic nitro-drugs used in the treatment of tuberculosis, including the recently approved drug delamanid, were reported as promising fast track options...
